Remember
 
 
At SpeculatingStocks You Can Discover Stocks, Post Anonymously, and React to Posts. Login is Optional.
Watch for Reactions to Your Posts or React Below to Other's Posts. Discover Stocks and Market Data.
     
 

March 5, 2015

SpeculatingStocks.com Stock Pick: Acura Pharmaceuticals, Inc. (ACUR)

Stock Price: $0.74


Acura Pharmaceuticals, Inc. is a speciality pharmaceutical company, in the business of researching, developing, and commercializing products to address medication abuse and misuse utilizing its proprietary Aversion and Impede technologies.

ACUR has products which include 1) Oxecta tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; 2) Nexafed, a pseudoephedrine HCl tablet that is used as a nasal decongestant in various non-prescription and prescription cold, sinus, and allergy products and 3) seven additional opioid products.

ACUR has some interesting technology known as NEXAFED® Sinus Pressure + Pain [pseudoephedrine HCI 30mg + acetaminophen 325mg], a meth-resistant immediate-release tablet. NEXAFED Sinus Pressure + Pain will continue to utilize NEXAFED's unique, patented IMPEDE® technology that disrupts the conversion of PSE into the dangerous drug methamphetamine (meth), and will be the first meth-resistant PSE combination sinus medicine available. 

ACUR's patented technology holds a lot of potential to recieve greater adoption. Right now, ACUR is trading at a market cap of only $36.22 million. The company was recently upgraded by from a "Hold" to "Buy" from MLV & Co.

ACUR recently climbed from $0.50 to as high as $1.15 and recently filled its Feb. 27th gap higher. It looks like ACUR is at a great point in its chart with significantly increased volume interest the past 5 trading days.

Speculative Score: 8

1 Being the Least Speculative and Most Confident

10 Being the Most Speculative and Possibly the Most Risky

 

 
     
Untitled Document